These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 33469836)

  • 1. In silico transcriptomic mapping of integrins and immune activation in Basal-like and HER2+ breast cancer.
    Rojas K; Baliu-Piqué M; Manzano A; Saiz-Ladera C; García-Barberán V; Cimas FJ; Pérez-Segura P; Pandiella A; Győrffy B; Ocana A
    Cell Oncol (Dordr); 2021 Jun; 44(3):569-580. PubMed ID: 33469836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonality, Antigen Recognition, and Suppression of CD8
    Hammerl D; Massink MPG; Smid M; van Deurzen CHM; Meijers-Heijboer HEJ; Waisfisz Q; Debets R; Martens JWM
    Clin Cancer Res; 2020 Jan; 26(2):505-517. PubMed ID: 31649042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptomic Profiles of CD47 in Breast Tumors Predict Outcome and Are Associated with Immune Activation.
    Noblejas-López MDM; Baliu-Piqué M; Nieto-Jiménez C; Cimas FJ; Morafraile EC; Pandiella A; Corbi ÁL; Győrffy B; Ocaña A
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Immune Microenvironment in Hormone Receptor-Positive Breast Cancer Before and After Preoperative Chemotherapy.
    Waks AG; Stover DG; Guerriero JL; Dillon D; Barry WT; Gjini E; Hartl C; Lo W; Savoie J; Brock J; Wesolowski R; Li Z; Damicis A; Philips AV; Wu Y; Yang F; Sullivan A; Danaher P; Brauer HA; Osmani W; Lipschitz M; Hoadley KA; Goldberg M; Perou CM; Rodig S; Winer EP; Krop IE; Mittendorf EA; Tolaney SM
    Clin Cancer Res; 2019 Aug; 25(15):4644-4655. PubMed ID: 31061067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of a novel prognostic signature based on an identified expression profile of integrin superfamily to predict overall survival of patients with colorectal adenocarcinoma.
    Yu J; Yang K; Zheng J; Sun X; Zhao W
    Gene; 2022 Jan; 808():145990. PubMed ID: 34624456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-expression modules identified from published immune signatures reveal five distinct immune subtypes in breast cancer.
    Amara D; Wolf DM; van 't Veer L; Esserman L; Campbell M; Yau C
    Breast Cancer Res Treat; 2017 Jan; 161(1):41-50. PubMed ID: 27815749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune infiltrates in the breast cancer microenvironment: detection, characterization and clinical implication.
    Burugu S; Asleh-Aburaya K; Nielsen TO
    Breast Cancer; 2017 Jan; 24(1):3-15. PubMed ID: 27138387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Therapeutic Targets and Prognostic Biomarkers Among Integrin Subunits in the Skin Cutaneous Melanoma Microenvironment.
    Nurzat Y; Su W; Min P; Li K; Xu H; Zhang Y
    Front Oncol; 2021; 11():751875. PubMed ID: 34660316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of DRP1 as a prognostic factor correlated with immune infiltration in breast cancer.
    Liu B; Fan Y; Song Z; Han B; Meng Y; Cao P; Tan K
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107078. PubMed ID: 33049497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer.
    Bense RD; Sotiriou C; Piccart-Gebhart MJ; Haanen JBAG; van Vugt MATM; de Vries EGE; Schröder CP; Fehrmann RSN
    J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27737921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
    Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
    Front Immunol; 2019; 10():6. PubMed ID: 30761122
    [No Abstract]   [Full Text] [Related]  

  • 12. Construction and validation of an immunity-related prognostic signature for breast cancer.
    Zhu T; Zheng J; Hu S; Zhang W; Zhou H; Li X; Liu ZQ
    Aging (Albany NY); 2020 Nov; 12(21):21597-21612. PubMed ID: 33216733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic Signatures of Immune Activation Predict Outcome in Advanced Stages of Ovarian Cancer and Basal-Like Breast Tumors.
    Alcaraz-Sanabria A; Baliu-Piqué M; Saiz-Ladera C; Rojas K; Manzano A; Marquina G; Casado A; Cimas FJ; Pérez-Segura P; Pandiella A; Gyorffy B; Ocana A
    Front Oncol; 2019; 9():1486. PubMed ID: 31998644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma.
    Mito I; Takahashi H; Kawabata-Iwakawa R; Ida S; Tada H; Chikamatsu K
    Sci Rep; 2021 Aug; 11(1):16134. PubMed ID: 34373557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive evaluation of methods to assess overall and cell-specific immune infiltrates in breast cancer.
    Nederlof I; De Bortoli D; Bareche Y; Nguyen B; de Maaker M; Hooijer GKJ; Buisseret L; Kok M; Smid M; Van den Eynden GGGM; Brinkman AB; Hudecek J; Koster J; Sotiriou C; Larsimont D; Martens JWM; van de Vijver MJ; Horlings HM; Salgado R; Biganzoli E; Desmedt C
    Breast Cancer Res; 2019 Dec; 21(1):151. PubMed ID: 31878981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of ANXA1 as a potential prognostic biomarker and correlating with immune infiltrates in colorectal cancer.
    Liang Z; Li X
    Autoimmunity; 2021 Mar; 54(2):76-87. PubMed ID: 33596760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptomic immunologic signature associated with favorable clinical outcome in basal-like breast tumors.
    Martínez-Canales S; Cifuentes F; López De Rodas Gregorio M; Serrano-Oviedo L; Galán-Moya EM; Amir E; Pandiella A; Győrffy B; Ocaña A
    PLoS One; 2017; 12(5):e0175128. PubMed ID: 28472085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases.
    Tabariès S; Ouellet V; Hsu BE; Annis MG; Rose AA; Meunier L; Carmona E; Tam CE; Mes-Masson AM; Siegel PM
    Breast Cancer Res; 2015 Mar; 17(1):45. PubMed ID: 25882816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal promoter DNA hypermethylation of the integrin, nidogen, and dystroglycan genes in breast cancer.
    Strelnikov VV; Kuznetsova EB; Tanas AS; Rudenko VV; Kalinkin AI; Poddubskaya EV; Kekeeva TV; Chesnokova GG; Trotsenko ID; Larin SS; Kutsev SI; Zaletaev DV; Nemtsova MV; Simonova OA
    Sci Rep; 2021 Jan; 11(1):2264. PubMed ID: 33500458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of FOXP3+ tumor-infiltrating lymphocytes in breast cancer depends on estrogen receptor and human epidermal growth factor receptor-2 expression status and concurrent cytotoxic T-cell infiltration.
    Liu S; Foulkes WD; Leung S; Gao D; Lau S; Kos Z; Nielsen TO
    Breast Cancer Res; 2014 Sep; 16(5):432. PubMed ID: 25193543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.